Annelise vuidepot

Company: Immunocore Ltd

Job title: Chief Technology Officer & Head of Pipeline & Platform Research Site

Seminars:

ImmTACs, a Novel Class of Soluble Bispecifics: What Have We Learned So Far? 9:30 am

Overview of the technology & challenges associated with the platform Clinical proof of concept Development of a new ImmTac against PIWIL-1, a novel colorectal cancer targetRead more

day: Day Two